GBA1 and Parkinson disease: Motor, cognitive, olfactory and psychiatric symptoms have been reported to be more severe in PD patients with the severe GBA1 variants causing neuronopathic GD (type II GD) compared to those with the mild GBA1 variants causing non-neuronopathic GD30.